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Background: To determine the frequency of nonsyndromic cleft lip and/or palate (NSCL/P) in first-degree rela-
tives and to analyze the prevalence of tooth agenesis in patients with gastric cancer. 
Material and Methods: This cross-sectional, observational, case-control study included 798 patients attended at 
hospital Santa Casa in Montes Claros, Minas Gerais and Alfa Institute of Gastroenterology of the Federal Uni-
versity of the Minas Gerais. Information on basic demographic data and tooth agenesis of both groups and their 
family history of NSCL/P in first-degree relatives were evaluated. The collected information was stored in a 
database and analyzed using statistical program SPSS® version 21.0 and the values with p<0.05 were considered 
statistically significant. 
Results: Of the 798 patients, 113 (14.16%) consisted of the case group and 685 of the control group (85.84%). Non-
Caucasian males were the most affected, although no differences among the groups were detected. Of all partici-
pants (n=798), 66 (8.27%) presented tooth agenesis and 25 (3.13%) presented oral cleft in first degree relative. 
Conclusions: Our results no found increase in the frequency of tooth agenesis in patients with gastric cancer and 
in the frequency of NSCL/P in the first-degree relatives of patients with gastric cancer.
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Introduction
Nonsyndromic cleft lip and/or palate (NSCL/P) repre-
sents the most common orofacial birth defect, occurring 
in 1 in 500-2500 live births worldwide (1). In Brazil, the 
prevalence varies from 0.36 to 1.54 cases per 1000 live 
births (1,2). NSCL/P may be the result of a complex in-
terplay between environmental exposures, genetic and 
epigenetic factors. Although in the past decade multiple 
genetic variants were associated with NSCL/P, provid-
ing valuable insights into its genetic etiology, the dis-
ease-susceptibility genes identified so far, only account 
for a small percentage of cases (3). Moreover, relatively 
few studies have investigated the association between 
genetic variants and environmental factors in NSCL/P 
(4). 
It has been proposed that cancer and congenital mal-
formations such as NSCL/P may occasionally have 
a common etiology. The underlying concept is that 
the same genes can act in both normal and malignant 
development (5,6). In the last years, epidemiological 
studies have assessed the relationship between cancer 
and NSCL/P in different populations (Texas, USA (7), 
France (8), Pittsburgh, USA (9), Latvia (6), Netherlands 
(10), Southeast Asian (11), and Brazil (12-14). Factors 
that have been suspected to be at the basis of these as-
sociations are polymorphic variants in genes involved 
in cell-to-cell adhesion and cell motility (6,15).
Cancer is a multifactorial disease in which both genetic 
and environmental factors play a significant role. Pre-
ventive plans for decreasing cancer incidence include 
both the removal of environmental agents known to be 
carcinogens and the identification of cancer susceptibil-
ity gene polymorphisms or mutations (16). 
Gastric cancer is the fourth most common malignan-
cy and the second leading cause of death due to can-
cer worldwide (17). In Brazil, the estimate for the year 
2016, points to the occurrence of approximately 12,920 
new cases of gastric cancer in men and 7,600 cases in 
women. These values correspond to an estimated risk 
of 13.19 new cases per 100,000 men and 7.41 cases per 
100,000 women (18).
Studies have shown the relationship between cancer and 
dental anomalies (19,20), and other studies have shown 
the relationship between NSCL/P and dental anomalies 
(21,22). Hence, the aim of the current study is to deter-
mine the frequency of NSCL/P in first-degree relatives 
of patients with gastric cancer and to analyze the preva-
lence of tooth agenesis in patients with gastric cancer.
Material and Methods
After proper approval of the State University of Mon-
tes Claros, Brazil, Institutional Review Board, 798 in-
dividuals were evaluated, 113 with gastric cancer were 
identified at the Oncology Clinic of the hospital Santa 
Casa, in the city of Montes Claros, Minas Gerais, and 
at the Alfa Institute of Gastroenterology of the Federal 
University of the State of Minas Gerais, in the city of 
Belo Horizonte, and 685 without gastric cancer or any 
syndrome were identified randomly at the General Clin-
ics of Santa Casa in Montes Claros). All subjects from 
both groups (case and control) answered a question-
naire with questions about basic demographic informa-
tion and their family history of NSCL/P in first-degree 
relatives (mother, father, son, daughter, siblings) and 
the evaluation of tooth agenesis was performed based 
on dental status and history. All permanent teeth were 
investigated, excluding third molars. The analyses fo-
cused on the type and number of missing teeth, the av-
erage number of missing teeth per patient. It was not 
identified any person with associated syndromes. The 
term hypodontia used to describe only a few missing 
teeth, while oligodontia refers to a more severe anomaly 
with six or more missing teeth (23). 
The collected information was stored in a database and 
analysed using statistical program SPSS® version 21.0 
(Statistical Package for Social Sciences for Windows®, 
Inc., USA). Statistical analyses were also carried out us-
ing Fisher’s exact test (expected frequency values fell 
below 5) and odds ratio (OR) with a confidence inter-
val of 95% (95% CI) to estimate the magnitude of the 
risk. Values with p<0.05 were considered statistically 
significant.
Results
From a total of 798 individuals of this study, 467 
(58.53%) were female and 331 (41.47%) were male. In the 
case group, from the total of 113 patients, 67 (59.29%) 
were male and 46 (40.71%) female (p=0.000). The aver-
age age of the cases diagnosed with gastric cancer was 
62.41 years (standard deviation ± 14.68 years). The av-
erage age of the unaffected individuals was 57.14 years 
(standard deviation ± 14.34 years). The age distribution 
was not different between affected and unaffected indi-
viduals (p=0.017) (Table 1).
From the 113 patients with gastric cancer, 4 (3.54%) had 
a positive history of NSCL/P, and in the control group, 
21 individuals (3.06%) had a family history of NSCL/P 
(chi-square with 1 degree of freedom, p=0.77; CI 95%, 
0.39–3.44). Regarding the presence of tooth agenesis be-
tween individuals of case and control group, it was found 
that in the first 11 patients with gastric cancer (9.73%) 
presented agenesis, while in the control group, 55 indi-
viduals (8.03%) presented the dental anomaly (chi-square 
with 1 degree of freedom, p=0.54; CI 95%, 0.62–2.43) 
(Table 1). In all individuals of both groups, there were 
found only cases of hypodontia and no oligodontia. In 
patients with gastric cancer and in the control group there 
was a predominance of agenesis of maxillary lateral inci-
sors. No general difference in the frequency of agenesis 
between the left and right sides was found.







Gender    
Female 46(9.9) 421(90.1)  
Male 67(20.2) 264(79.8) 0.000 
Race/ethnicity    
Caucasian 43(15.6) 232(84.4)  
Non-Caucasian 70(13.4) 453(86.6) 0.386 
Age    
>50 years 89(16.1) 463(83.9)  
≤ 50 years 24(9.8) 222(90.2) 0.017 
Orofacial cleft in 1st degree relative    
Yes 4(16.0) 21(84.0)  
No 109(14.1) 664(85.9) 0.770 
Cleft type    
Cleft lip 2(9.5) 19(90.5)  
Cleft lip and palate 1(50.0) 1(50.0)  
Cleft palate 1(50.0) 1(50.0) 0.129 
Cleft side    
Unilateral 1(5.3) 18(94.7)  
Bilateral 2(40.0) 3(60.0) 0.099 
Tooth agenesis    
Yes 11(16.7) 55(83.3)  
No 102(13.9) 630(86.1) 0.542 
Localization of tooth agenesis     
UCI - LCI 4(40.0) 6(60.0)  
ULI - LLI 3(25.0) 9(75.0)  
UC - LC 1(11.1) 8(88.9)  
1º UPM - 1ºLPM 1(16.7) 5(83.3)  
2ºUPM - 2ºLPM 0(0.0) 3(100.0)  
1ºUM - 1ºLM 1(14.3) 6(85.7)  
2ºUM - 2ºLM 1(5.6) 17(94.4)  
More of one tooth agensesis 0(0.0) 1(100.0) 0.414 




Table 1: Characteristics of patients with gastric cancer and family history of Nonsyndromic cleft lip and/or palate.
*UCI - Upper central incisor, ULI - Upper lateral incisor, LCI - Lower central incisor, LLI - Lower lateral incisor, 
UC - Upper canine, LC - Lower canine, UPM - Upper premolar, LPM - Lower premolar, UM - Upper molar, LM - 
Lower molar.
In relation to ethnicity, in both groups there was a prev-
alence of non-Caucasians (case group: 61.94% versus 
38.05% and control group: 66.13% versus 33.86%). The 
ancestry of individuals studied previously in the same 
place (Minas Gerais State, Brazil) was held (24). The 
average ancestry contributions to patients with NSCL/P 
were estimated as 87.5% European, 10.7% African, and 
1.8% Amerindian. These results were similar to those of 
the control subjects (90% European, 7.5% African, and 
2.5% Amerindian) (24).
Discussion
Previous studies have shown that a high risk of oral 
clefts may exist in families where a cancer case has been 
identified (20,25). The increased occurrence of NSCL/P 
in hereditary diffuse gastric cancer (HDGC) patients 
with a CDH1 mutation was suggested by Frebourg et 
al. (8) and supported by Kluijit et al. (10). Recently, the 
incorporation of a family history of orofacial cleft was 
suggested into the new HDGC-defining criteria (11). In 
a recent study, we suggest that polymorphic variants 
in AXIN2 and CDH1 may be associated with NSCL/P 
susceptibility, and reinforce the putative link between 
cancer and oral clefts (20).
However, in the present study, the frequency of NSCL/P 
was not significantly increased in the first-degree rela-
tives of women with gastric cancer. These results agree 
with a recent study in which we show that the frequency 
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of NSCL/P was not significantly increased in the first-
degree relatives of women with breast cancer (13). In 
a systematic review of the literature, an increased risk 
of cancer among relatives of individuals with NSCL/P 
could not be entirely confirmed (15).
More than 300 genes are involved in odontogenesis, and 
mutations in several of these genes have been linked with 
hypodontia (26). The genes that control the development 
of teeth also have important functions in other organs 
and body systems (26). A Finnish family was described 
in which a nonsense mutation in AXIN2 was found to co-
segregate with an oligodontia phenotype (19). 
The present study, involving patients with gastric can-
cer showed no increase in the frequency of dental agen-
esis, compared to patients without cancer. Our results 
are consistent with a study involving colorectal cancer 
and tooth agenesis (27). Bonds et al. (23) evaluated the 
relationship between ovarian cancer and tooth agenesis. 
Although the results did not show a direct relation be-
tween the two conditions, the authors proposed studies 
with broader populations. However, Küchler et al. (28) 
observed an increased frequency of familial history of 
breast cancer and prostate cancer in individuals with 
at least one missing premolar as well as an increased 
frequency of all cancers in the group with at least one 
missing upper lateral incisor. Chalothorn et al. (26) 
described an increased prevalence of hypodontia in 
women with epithelial ovarian cancer. Twenty percent 
of these women reported one or two missing teeth, ver-
sus three percent in a cancer-free control sample. These 
results were confirmed recently (29). The study shows 
a prevalence of hypodontia in 19.2% of women with 
epithelial ovarian cancer and in 6.7% of women in the 
control group.
The hypothesized association between cancer and 
NSCL/P could be attributed to factors that have been 
suspected to be at the basis of these associations, which 
are polymorphic variants in genes involved in cell-to-
cell adhesion and cell motility (15). Limitations of our 
study were the relatively small number of patients with 
gastric cancer. Studies with larger samples and molecu-
lar analyses are needed to better understand the possible 
relationships in the etiology of cancer and NSCL/P.
Conclusions
Our results suggest that the frequency of NSCL/P was not 
significantly increased in the first-degree relatives of wom-
en with gastric cancer. It was also observed that patients 
with gastric cancer showed no increase in the frequency of 
tooth agenesis, compared to patients without cancer.
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